These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 21873895)
1. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. Maldonado J; Cañabate F; Sempere L; Vela F; Sánchez AR; Narbona E; López-Huertas E; Geerlings A; Valero AD; Olivares M; Lara-Villoslada F J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):55-61. PubMed ID: 21873895 [TBL] [Abstract][Full Text] [Related]
2. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial. Maldonado-Lobón JA; Gil-Campos M; Maldonado J; López-Huertas E; Flores-Rojas K; Valero AD; Rodríguez-Benítez MV; Bañuelos O; Lara-Villoslada F; Fonollá J; Olivares M Pharmacol Res; 2015; 95-96():12-9. PubMed ID: 25697549 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial. Maldonado J; Gil-Campos M; Maldonado-Lobón JA; Benavides MR; Flores-Rojas K; Jaldo R; Jiménez Del Barco I; Bolívar V; Valero AD; Prados E; Peñalver I; Olivares M BMC Pediatr; 2019 Oct; 19(1):361. PubMed ID: 31630683 [TBL] [Abstract][Full Text] [Related]
4. Probiotics: fishing in the ocean. Vandenplas Y; Veereman-Wauters G J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):4-5. PubMed ID: 21873896 [No Abstract] [Full Text] [Related]
5. Efficacy and safety of a synbiotic infant formula for the prevention of respiratory and gastrointestinal infections: a randomized controlled trial. Piloquet H; Vrignaud B; Gillaizeau F; Capronnier O; Berding K; Günther J; Hecht C; Regimbart C; Am J Clin Nutr; 2024 May; 119(5):1259-1269. PubMed ID: 38462218 [TBL] [Abstract][Full Text] [Related]
6. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Gil-Campos M; López MÁ; Rodriguez-Benítez MV; Romero J; Roncero I; Linares MD; Maldonado J; López-Huertas E; Berwind R; Ritzenthaler KL; Navas V; Sierra C; Sempere L; Geerlings A; Maldonado-Lobón JA; Valero AD; Lara-Villoslada F; Olivares M Pharmacol Res; 2012 Feb; 65(2):231-8. PubMed ID: 22155106 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of human breast milk Lactobacillus fermentum CECT 5716. A mini-review of studies with infant formulae. López-Huertas E Benef Microbes; 2015; 6(2):219-24. PubMed ID: 25519525 [TBL] [Abstract][Full Text] [Related]
8. Ozen M; Piloquet H; Schaubeck M Nutrients; 2023 May; 15(9):. PubMed ID: 37432320 [TBL] [Abstract][Full Text] [Related]